E. Beys

Preclinical profile of cabazitaxel

P. Vrignaud, Sunil Gupta, H. Bouchard, 2014, Drug design, development and therapy.

Preclinical Activity of SAR408701: A Novel Anti-CEACAM5–maytansinoid Antibody–drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors

C. García-echeverría, C. Nicolazzi, J. Mayaux, 2020, Clinical Cancer Research.

Evaluation of tissue perfusion (tumor, spleen, heart) in mice after administration of AVE8062, a tumor vascular-targeting agent

P. Vrignaud, M. Bissery, M. Guffroy, 2004 .

Subchronic toxicity studies with the leukotriene D4 antagonist RG 12525.

J. E. Sanders, D. Kornbrust, Z. Jayyosi, 1995, Fundamental and Applied Toxicology.

Ovarian changes in Sprague-Dawley rats produced by nocturnal exposure to low intensity light

T. Hodge, G. Nohynek, E. Beys, 1995, Laboratory animals.

Abstract LB-053: Towards new cryptophycins as promising payloads for ADC

F. Clerc, C. Nicolazzi, I. Sassoon, 2016 .